LC3 dot-like immunostaining is correlated with shorter survival in KRAS mutated CRC, whereas high cytoplasmic p62 is negatively associated with poor survival in KRAS mutated CRC [20]. This evidence concerns the gene MAP1LC3A and colorectal carcinoma.